Bausch Health Companies | VRX - Assets

Stock Price
7.77
Daily Change
0 0%
Monthly
-23.90%
Yearly
-26.28%
Q1 Forecast
7.62

Bausch Health Companies reported $26.82B in Assets for its fiscal quarter ending in September of 2025.





Assets Change Date
Amgen USD 90.14B 2.24B Sep/2025
ANI Pharmaceuticals USD 1.41B 65.15M Sep/2025
Aurora Cannabis CAD 756.86M 80.98M Sep/2025
Bausch Health Companies USD 26.82B 442M Sep/2025
Biogen USD 29.21B 877.3M Sep/2025
Bristol-Myers Squibb USD 96.89B 2.21B Sep/2025
Canopy Growth CAD 1.07B 165.17M Sep/2025
Corcept Therapeutics USD 823.61M 21.88M Sep/2025
Danaher USD 83.46B 3.57B Dec/2025
Drreddys Laboratories INR 6.26B 161.9M Dec/2025
Eli Lilly USD 114.94B 14.01B Sep/2025
Gilead Sciences USD 58.53B 2.81B Sep/2025
Novo Nordisk DKK 542.9B 30.61B Dec/2025
Pacira USD 1.3B 239.68M Sep/2025
Perrigo USD 10.08B 10.1M Sep/2025
Prestige Brands USD 3.44B 10.66M Sep/2025
Supernus Pharmaceuticals USD 1.42B 37.35M Sep/2025
Vertex Pharmaceuticals USD 24.86B 825.6M Sep/2025
Zoetis USD 15.16B 680M Sep/2025